Clinical trial Recruiting at 1 site Interventional Ages 2 to 6

VOJTA technique for children with ataxic cerebral palsy

Official title: Effects of VOJTA Technique on Muscle Tone, Gross Motor Function and Balance on Ataxic Cerebral Palsy.

Run by Lahore University of Biological and Applied Sciences · NCT07291128 · Data updated 2026-11-12

This trial will test whether VOJTA therapy helps children aged 2–6 with ataxic cerebral palsy improve muscle tone, balance, and gross motor skills.

Quick facts

Study typeInterventional
Ages2 Years to 6 Years
SexAll
Enrollment40 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedDecember 8, 2025
Main results expectedMay 2026
Study endsMay 2026
Registry record updatedDecember 30, 2025
Trial IDNCT07291128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–6 years with a diagnosis of ataxic cerebral palsy, gross motor function classification level 2, presence of ATNR reflex, and stable medical status for at least three months.

Probably not a fit

Children with severe neurological or orthopedic comorbidities, significant cognitive impairment, sensory deficits that affect balance, ongoing medications that alter muscle tone, or syndromic conditions (e.g., Down syndrome, hydrocephalus, epilepsy, autism) are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 40 children with ataxic cerebral palsy and assign them to either VOJTA therapy or conventional physiotherapy. Both groups receive supervised treatment five days per week for eight weeks, with outcomes measured at baseline, mid-treatment (4 weeks), and after treatment (8 weeks). VOJTA therapy uses specific pressure zones and reflex locomotion to activate central motor programs and potentially improve postural alignment and coordinated muscle activation. Primary outcomes include measures of muscle tone, gross motor function, and postural control.

Why it matters

Potential benefit: If successful, VOJTA therapy could improve muscle tone, balance, and coordination, helping affected children gain better mobility and daily functioning.

How similar studies have gone: VOJTA therapy has shown promising results in small studies and clinical reports for motor improvements in children with cerebral palsy, but high-quality randomized evidence—particularly for the ataxic subtype—is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Both male and female participants would be included

Children diagnosed with ataxic cerebral palsy.

Age range of participants will be 2 to 6 years old.

Participants included will be at level 2 on gross motor function classification scale.

Participants included will have ATNR reflex.

Stable medical condition for the past three months with no hospitalizations.

Exclusion Criteria:

Presence of severe comorbidities i.e. neurological or orthopedic conditions.

Patients having significant cognitive deficits

Down syndrome, hydrocephalus, epilepsy, autism and medically ill children

Children with visual or auditory deficits affecting postural control and balance assessment.

Ongoing pharmacological treatment (e.g., muscle relaxants or antiepileptic) likely to influence muscle tone or motor function during the study period

Where it's running

  • Department of Physical Therapy
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.